HORIZON-TMA-MSCA-DN

Protease‐guided tumor targeting tools to revolutionize cancer diagnosis and treatment

Source of Funding: European Commission

Period: 2022-2026

 

COST ACTION

European COST Action CA21145 “European Network for diagnosis and treatment of antibiotic-resistant bacterial infections (EURESTOP)”

Source of Funding: European Cooperation in Science and Technology (COST) actions

Period: 2022-2026

​

Inquiring the druggability of DNAG4-helicase interactions with small molecules (reference of the project 2022.06099.PTDC) 

Funding:  Fundação para a Ciência a Tecnologia

Period: 2023-2024

​

Potential of nitrobenzoic acid derivatives as antituberculosis drugs. Insights into the mechanism of action (reference of the project EXPL/SAU-INF/1097/2021)

Funding: Fundação para a Ciência a Tecnologia

Period: 2022-2023

​

Targeting mutant p53 with tryptophanol-derived small molecules (reference of the project PTDC/QUI-QOR/130/2020)
Funding: Fundação para a Ciência a Tecnologia

Period: 2021-present
Website >>


Bilateral cooperation - Programme for Cooperation in Science between Portugal and Hungary (FCT/NKTH) 2019-2022
Coordinators: Maria M. M. Santos (Portugal) and Attila Hunyadi (University of Szeged, Hungary)


A new approach to fight tuberculosis: co-drugs activated by mycobacterial esterases  (reference of the project PTDC/SAU-INF/28080/2017) 
2018-2022
Coordinator: Luís Constantino 
Funding: €229,181


Drug Discovery for p53 PPI-targets (reference of the project PTDC/QUI-QOR/29664/2017) 2018-2022
Coordinator: Maria M. M. Santos
Funding: €234,325 
Website >>